热门资讯> 正文

Viracta Therapeutics任命Michael Faerm为首席财务官

2024-05-14 19:25

Viracta Therapeutics (NASDAQ:VIRX) said it has appointed Michael Faerm as its CFO, effective immediately.
Faerm has more than 25 years of experience in life sciences companies, equity research and investment banking, and was recently the interim finance chief at Harpoon Therapeutics.

More on Viracta Therapeutics

Day One wins FDA nod for brain cancer therapy, Ojemda
Viracta slides on lower response rate in trial for lymphoma treatment cohort

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。